Hair Shedding, Hair Thinning
Conditions
Keywords
Hair growth, Female pattern hair loss, Hair health
Brief summary
This study evaluates the efficacy of Scale Media's HLV Clinical Formula Hair Vitamins on the health and appearance of hair, focusing on growth, volume, dullness, overall health, hair shedding, fullness, and strength. It is a randomized controlled trial with 50 female-at-birth participants experiencing self-perceived hair thinning.
Interventions
DIETARY_SUPPLEMENTScale HLV Clinical Formula Hair Vitamins
For the first week, participants will take 1 capsule in the morning and 2 capsules in the evening before food. From Week 2 onwards, participants will take 3 capsules daily in the evening before food.
OTHERPlacebo
For the first week, participants will take 1 capsule in the morning and 2 capsules in the evening before food. From Week 2 onwards, participants will take 3 capsules daily in the evening before food.
Sponsors
Citruslabs
Scale Media Inc
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
FEMALE
Age
35 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Female at birth, aged 35+. * Self-perceived hair thinning and increased hair shedding for at least three months. * Consistent hair care routine for at least one month prior. * Willing to maintain hair care routine, diet, and refrain from new vitamins or supplements targeting hair growth during the study. * Generally healthy without uncontrolled chronic diseases.
Exclusion criteria
* Hair loss conditions other than female pattern baldness. * Pregnant, breastfeeding, or trying to conceive. * Currently taking iron supplements or other hair growth treatments. * Significant chronic conditions or planned medical procedures that interfere with protocol adherence. * Recent chemical hair treatments or plans for such treatments during the study. * Severe allergic reactions to the product's ingredients. * Recent surgeries, major illnesses, or undergoing chemotherapy/radiotherapy.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Reduction in Hair Shedding | Baseline, Day 90, and Day 180 | Hair shedding will be measured through hair counts from the at-home comb test and hair health will be evaluated through expert dermatologist grading based on photos provided by participants. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Improvement in Hair Health Perception | Baseline, Day 30, Day 60, Day 90, Day 120, Day 150, and Day 180 | Participants' perceptions of the product's effect on overall hair health, including volume, dullness, fullness, and strength, will be evaluated through self-reported questionnaires. |
Countries
United States
Outcome results
None listed